Clinical Trial Update: Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated high-dose cyclophosphamide in patients with severe aplastic anemia and paroxysmal nocturnal hemoglobinuria. The trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Aplastic Anemia, Paroxysmal Hemoglobinuria, Nocturnal | Phase 2 | Status: COMPLETED